Why Shares of MannKind Corporation Climbed 10.4% on Monday
What happened Shares of MannKind Corporation (NASDAQ: MNKD), a biotech company that specializes in finding therapies for endocrine and orphan lung diseases, rose 10.4% on Monday. The stock closed at $3.